KAINOS Laboratories,Inc. [4556.T]
TOKYO, May 25 (Pulse News Wire) – Kainos Laboratories,inc. (4556.T) announced today that its shareholders approved share consolidation plans at their extraordinary general meeting held on May 25.
As a result, the company's ordinary shares will be delisted from the Tokyo Stock Exchange on June 11, 2026, following a designated period as a special watch stock from May 25 to June 10, 2026. Under the approved plan, the company’s outstanding shares will be consolidated at a ratio of 100-to-1, reducing the total number of issued shares from 1,000,000 to 18. The effective date of the share consolidation is set for June 15, 2026.
Following the consolidation, the company’s shares will no longer trade on the exchange due to non-compliance with listing requirements. Additionally, the company confirmed that any fractional shares resulting from the consolidation will be sold to Flowers Corporation, the tender offeror, through court approval. The proceeds from such sales will be distributed to affected shareholders.
The sale process is expected to commence in late June 2026, with distributions anticipated by September 2026.
🟢 Confidence: High AI-translated content.